GlaxoSmithKline: all 4,196 studies
Page 24 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- In Vivo Sun Protection Factor DeterminationCompletedNCT02792595Not applicable
- A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled SolutionCompletedNCT02751294Phase 1
- Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish ChildrenCompletedNCT02742753
- Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)CompletedNCT02741557Phase 1
- Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose CombinationsCompletedNCT02738931Phase 1
- A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607CompletedNCT02737007Phase 1
- A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT02731846Phase 3
- An Efficacy and Safety Study of Theraflu Night Powder as Oral Solution for Cold and FluWithdrawnNCT02730364Phase 3
- A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy VolunteersCompletedNCT02727283Phase 1
- A Study to Evaluate the Effect of BMS-955176 on Pharmacokinetics of Dolutegravir and the Effect of Dolutegravir on the Pharmacokinetics of BMS-955176CompletedNCT02715479Phase 1
- Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsActive, not recruitingNCT02715284Phase 1
- A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing PotentialCompletedNCT02706535Phase 1
- Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women VolunteersCompletedNCT02703181Phase 1
- A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy VolunteersCompletedNCT02698553Phase 1
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK2269557 Administered Via the ELLIPTA Dry Powder Inhaler to Healthy SubjectsCompletedNCT02691325Phase 1
- A Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and One Reference) in Healthy Adult SmokersCompletedNCT02688374Phase 1
- A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral SolutionCompletedNCT02688361Phase 1
- An Efficacy and Safety Study of Theraflu Day Powder as Oral Solution for Cold and FluWithdrawnNCT02678234Phase 3
- A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)CompletedNCT02674581Phase 1
- A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic ArthritisWithdrawnNCT02671188Phase 1
- GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)CompletedNCT02666287Phase 1
- A Study to Assess the Effect of High Fat Meal and Increased Gastric pH on the Bioavailability of an Extended Release Formulation of BMS-663068 in Healthy SubjectsCompletedNCT02666053Phase 1
- A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/NaloxoneCompletedNCT02666001Phase 1
- Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult SubjectsCompletedNCT02660736Phase 1
- Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)CompletedNCT02658435Phase 1
- Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting ConditionsCompletedNCT02658422Phase 1
- Skin Irritation Study of GSK2894512 CreamCompletedNCT02637206Phase 1
- Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & AsthmaCompletedNCT02619357Phase 1
- First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis PatientsCompletedNCT02612051Phase 1
- Taste Properties of HIV InhibitorCompletedNCT02608918Phase 1
- Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil)CompletedNCT02602002Phase 1
- Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male SubjectsCompletedNCT02578953Phase 1
- Study on Effects of BMS-955176 on the Pharmacokinetics of Probe SubstratesCompletedNCT02578277Phase 1
- A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy SubjectsTerminatedNCT02576119Phase 1
- Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.CompletedNCT02569879
- Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic Study of GSK2881078 and Study to Evaluate the Effect of CYP3A4 Inhibition on PK of GSK2881078CompletedNCT02567773Phase 1
- Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of AgeCompletedNCT02567747
- Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)CompletedNCT02567721
- A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School ChildrenWithdrawnNCT02551627Not applicable
- Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02551614Phase 1
- Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque PsoriasisCompletedNCT02548052Phase 1
- Safety, Tolerability and Pharmacokinetics (PK) Study of Oxytocin (GR121619) Administered Via an Inhaled Route in Healthy Female VolunteersCompletedNCT02542813Phase 1
- Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese SubjectsCompletedNCT02539576Phase 1
- New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle MassCompletedNCT02519751Not applicable
- Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese SubjectsCompletedNCT02513654Phase 1
- Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male SubjectsCompletedNCT02509104Phase 1
- Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release TabletCompletedNCT02508064Phase 1
- Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy SubjectsCompletedNCT02502812Phase 1
- A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed ConditionCompletedNCT02498288Phase 1
- A Open-label, Drug-Drug Interaction With Maraviroc (DDI)CompletedNCT02480894Phase 1
- A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)CompletedNCT02480881Phase 1
- Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With CancerCompletedNCT02476552Phase 1
- Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy SubjectsCompletedNCT02467335Phase 1
- Pharmacokinetic Study of Topical GSK2894512 CreamCompletedNCT02466152Phase 1
- Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent ExerciseCompletedNCT02458599Not applicable
- A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With OmeprazoleCompletedNCT02453022Phase 1
- Duration of Protection: GSK DTaP VaccinesCompletedNCT02447978
- Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With MelanomaWithdrawnNCT02447939Phase 1
- Phase 1 Study of LevocetirizineCompletedNCT02447393Phase 1
- Clinical Efficacy of Fluoride Toothpastes Using an In Situ Caries ModelWithdrawnNCT02436473Not applicable
- An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy SubjectsCompletedNCT02434861Phase 1
- Efficacy of a Carbohydrate Drink on Speed, Agility and Power in School Going ChildrenCompletedNCT02428127Not applicable
- Impact of Beverage Powder With Micronutrients and Brahmi Extract on Cognitive Variables in Indian School ChildrenCompletedNCT02416245Not applicable
- Access Study of Trametinib for Subjects With Advanced Unresectable (Stage IIIc) or Distant Metastatic (Stage IV) BRAF V600E/K Mutation Positive Cutaneous MelanomaNo longer availableNCT02416232
- Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsCompletedNCT02411435Phase 1
- A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 CreamCompletedNCT02411162Phase 1
- Local Skin Safety Study of a Topical Pain Relief Spray Containing a Combination of Diclofenac, Methyl Salicylate, and MentholWithdrawnNCT02400320Phase 4
- A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of GSK2330811 in Healthy SubjectsCompletedNCT02386436Phase 1
- A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy VolunteersCompletedNCT02382666Phase 1
- Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or AibrateroneWithdrawnNCT02380313Phase 1
- Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese WomenCompletedNCT02377414Phase 1
- Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese AdultsCompletedNCT02377401Phase 1
- Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy SubjectsCompletedNCT02373930Phase 1
- Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult VolunteersCompletedNCT02371603Phase 1
- Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue SarcomaWithdrawnNCT02367651Phase 2
- A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy VolunteersCompletedNCT02354950Phase 1
- Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal ImpairmentCompletedNCT02354937Phase 1
- A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging TechniquesTerminatedNCT02350426Phase 1
- Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy SubjectsCompletedNCT02348372Phase 1
- Relative Bioavailability Study of Phase III Tablet Formulation of CabotegravirCompletedNCT02345707Phase 1
- fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation.CompletedNCT02345187Not applicable
- Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid TumorsCompletedNCT02345174Phase 1
- Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in GermanyCompletedNCT02342769
- First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT02335814Phase 1
- This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of AgeCompletedNCT02324218
- Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult SubjectsCompletedNCT02322671Phase 1
- Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02302417Phase 2
- A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male SubjectsCompletedNCT02302404Phase 1
- Cross-sectional Study for Identification and Description of Severe Asthma PatientsCompletedNCT02293265Phase 3
- Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy VolunteersCompletedNCT02293161Phase 1
- Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy VolunteersCompletedNCT02293148Phase 1
- A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid TumorsWithdrawnNCT02292732Phase 1
- A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsTerminatedNCT02289495Phase 1
- A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsTerminatedNCT02289482Phase 1
- An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous RolapitantCompletedNCT02285647Phase 1
- Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy SubjectsCompletedNCT02281370Phase 1
- A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)CompletedNCT02277600Phase 1
- Food Effect Study With BMS-955176CompletedNCT02273947Phase 1
- Panadol Osteo Pharmaceuticals Benefit Scheme (PBS) Claims Cohort StudyWithdrawnNCT02262702
- To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic ConditionsCompletedNCT02262689Phase 1